Target intelligence / Profile preview

Apicoplast ribosome peptidyl transferase center (Apicoplast PTC)

Target
Apicoplast PTC
Molecular classification
Ribonucleoprotein, Enzyme, Ribosome
01

Overview

The apicoplast ribosome peptidyl transferase center (PTC) is the catalytic core of the protein synthesis machinery located within the apicoplast, a non-photosynthetic plastid essential for the survival of Apicomplexan parasites such as Plasmodium falciparum and Toxoplasma gondii (Source: PubMed, PMID: 17703225). This site is primarily composed of the 23S ribosomal RNA and is responsible for catalyzing peptide bond formation during the elongation phase of translation. Because the apicoplast is of endosymbiotic prokaryotic origin, its ribosome shares high structural homology with bacterial ribosomes but differs significantly from the eukaryotic 80S ribosomes of the human host (Source: UniProt). This structural divergence allows for selective targeting by various antibiotics, including macrolides, lincosamides, and chloramphenicol, which bind to the PTC and obstruct protein synthesis (Source: PMC, PMC3384643). A unique feature of targeting this site is the delayed death phenomenon, where the parasite's progeny fail to survive despite the initial generation appearing unaffected (Source: PubMed, PMID: 9192655). Consequently, the apicoplast PTC is a validated therapeutic target for treating malaria and toxoplasmosis, though its slow-acting nature often requires combination therapy with faster-acting agents.

Other names
Apicoplast 50S ribosomal subunitApicoplast 23S rRNA peptidyl transferase centerPlastid ribosomal peptidyl transferase centerApicoplast large ribosomal subunit
02

Mechanism of action

Inhibition of protein translation by binding to the 50S ribosomal subunit and blocking the peptidyl transferase reaction, preventing peptide bond formation and nascent chain elongation.

03

Biological functions

Protein synthesisTranslationPeptide bond formation
04

Disease associations

MalariaToxoplasmosisBabesiosisInfection
05

Safety considerations

Mitochondrial toxicity due to structural similarity between apicoplast and human mitochondrial ribosomesDelayed onset of action (delayed death phenomenon)Gastrointestinal distressPotential for antibiotic resistance development
06

Interacting drugs

Clindamycin

5 more in the full profile.

07

Biomarkers

ParasitemiaDelayed death phenotype

Beyond the preview

Go deeper on Apicoplast ribosome peptidyl transferase center (Apicoplast PTC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apicoplast ribosome peptidyl transferase center (Apicoplast PTC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call